NIEHS/FDA CLARITY-BPA research program update

Jerrold J. Heindel, Retha R. Newbold, John R. Bucher, Luísa Camacho, K. Barry Delclos, Sherry M. Lewis, Michelle Vanlandingham, Mona I. Churchwell, Nathan C. Twaddle, Michelle McLellen, Mani Chidambaram, Matthew Bryant, Kellie Woodling, Gonçalo Gamboa da Costa, Sherry A. Ferguson, Jodi Flaws, Paul C. Howard, Nigel J. Walker, R. Thomas Zoeller, Jennifer FostelCarolyn Favaro, Thaddeus T. Schug

Research output: Contribution to journalReview articlepeer-review


Bisphenol A (BPA) is a chemical used in the production of numerous consumer products resulting in potential daily human exposure to this chemical. The FDA previously evaluated the body of BPA toxicology data and determined that BPA is safe at current exposure levels. Although consistent with the assessment of some other regulatory agencies around the world, this determination of BPA safety continues to be debated in scientific and popular publications, resulting in conflicting messages to the public. Thus, the National Toxicology Program (NTP), National Institute of Environmental Health Sciences (NIEHS), and U.S. Food and Drug Administration (FDA) developed a consortium-based research program to link more effectively a variety of hypothesis-based research investigations and guideline-compliant safety testing with BPA. This collaboration is known as the Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA). This paper provides a detailed description of the conduct of the study and a midterm update on progress of the CLARITY-BPA research program.

Original languageEnglish (US)
Pages (from-to)33-44
Number of pages12
JournalReproductive Toxicology
StatePublished - Dec 1 2015


  • Bisphenol A
  • Consortium
  • Endocrine disruptors
  • FDA
  • NTP

ASJC Scopus subject areas

  • Toxicology


Dive into the research topics of 'NIEHS/FDA CLARITY-BPA research program update'. Together they form a unique fingerprint.

Cite this